Life Science REIT (LON:LABS) Trading 1.8% Higher – Time to Buy?

Life Science REIT plc (LON:LABS)’s share price rose 1.8% during trading on Friday . The company traded as high as GBX 40.70 ($0.53) and last traded at GBX 40.50 ($0.53). Approximately 316,170 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,053,393 shares. The stock had previously closed at GBX 39.80 ($0.52).

Analyst Ratings Changes

LABS has been the topic of a number of research reports. Jefferies Financial Group lowered their target price on Life Science REIT from GBX 45 ($0.58) to GBX 36 ($0.47) and set a “hold” rating on the stock in a research report on Friday, August 30th. Shore Capital restated a “buy” rating on shares of Life Science REIT in a research note on Thursday, September 26th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 57 ($0.74) price objective on shares of Life Science REIT in a research note on Thursday, October 3rd.

Life Science REIT Trading Up 1.8 %

The business has a fifty day simple moving average of GBX 35.85 and a 200 day simple moving average of GBX 35.80. The stock has a market capitalization of £141.75 million, a P/E ratio of -675.00 and a beta of 0.08.

Life Science REIT Dividend Announcement

The business also recently declared a dividend, which will be paid on Thursday, October 31st. Investors of record on Thursday, October 3rd will be given a GBX 1 ($0.01) dividend. This represents a yield of 3.11%. The ex-dividend date is Thursday, October 3rd. Life Science REIT’s payout ratio is currently -3,333.33%.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.